Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 79353163 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
2022-07-06 | Application Filed |
2022-10-20 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2022-10-20 | Status: Live/Pending |
2022-10-31 | Transaction Date |
Owner: | ![]() |
Entity Statement | Limited Company |
Address | 16 Southside Quarter, 38 Burns Road London SW11 5GY GB |
Legal Entity Type | |
Legal Entity State | GB |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0051 | Pharmaceuticals; antibacterial preparations; antibiotic preparations; antiviral and anti-infectious preparations; anti-inflammatory preparations; preparations for dermatological uses; medicinal preparations for slimming purposes; antiseptics, disinfectants; diagnostic preparations for medical purposes; natural remedies; tinctures for medical purposes; herbal health preparations and remedies; cough remedies, remedies for colds; pharmaceutical preparations derived from natural substances for remedial purposes; nasal sprays, nasal rinse, nasal drops, nasal decongestants; allopathic remedies; homeopathic remedies; teas and preparations for medicinal use; herbal oils adapted for medical use, herbs for medical uses; roots for medicinal purposes; peels for medicinal purposes; medicated hair lotions and shampoos; skin care lotions and creams (medicated); dietary and nutritional supplements for human beings; mineral nutritional supplements; vitamins supplements; dietetic substances adapted for medical use; food for babies and infants; infant formula; dietary fibre; protein powder dietary supplements; plasters, materials for dressings, hydrogel dressings |
GS0051 | Pharmaceuticals for the prevention and treatment of iron disorders, allergies, skin disorders, immune system related diseases and disorders; Pharmaceuticals preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, herpetological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders in domestic animals; Antibacterial preparations for human absorption and consumption, namely, antibacterial pharmaceuticals, antibacterial spray, antibacterial substance for medical purposes, antibacterial hand lotions; antibiotic preparations; antiviral and anti-infectious preparations, namely, antivirals, pharmaceutical products for the treatment of infectious diseases or viral infections; anti-inflammatory preparations; pharmaceutical preparations for dermatological uses; medicinal preparations for slimming purposes; antiseptics, disinfectants; diagnostic preparations for medical purposes; natural remedies in the nature of preparations for the treatment of gastrointestinal conditions, hormonal and chemical imbalance, immune system related diseases and disorders, sleep disorders; herbal tinctures for medical purposes; herbal health preparations and remedies, namely, herbal supplements, remedies in the form of chewable tablets, for boosting energy, boosting immune system, promoting healthy skin; cough remedies, namely, cough syrups, cough lozenges, cough treatment preparations; remedies for colds, namely, preparations for treating colds; pharmaceutical preparations derived from natural substances for remedial purposes, namely, for treating viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, herpetological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; nasal sprays for medical purposes, nasal rinse, nasal drops for treatment of allergies, nasal decongestants; allopathic remedies, namely, pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; homeopathic remedies, namely, homeopathic supplements, homeopathic pharmaceuticals for use in the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genito-urinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; herbal tea preparations for medicinal use; herbal oils being herbal extracts adapted for medical use, herbs for medicinal uses; roots for medicinal purposes; peels for medicinal purposes in the nature of medicated skin care preparations; medicated hair lotions and shampoos; medicated skin care lotions and creams; dietary and nutritional supplements for human beings; mineral nutritional supplements; vitamin supplements; dietetic substances, namely, preparations, chews, tablets adapted for medical use; food for babies and infants; infant formula; dietary fibre for treating constipation, aiding digestion; protein powder dietary supplements; medical plasters |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2022-10-20 | 1 REPR M: |
LIMITATION FROM ORIGINAL APPLICATION ENTERED | 2022-10-27 | 2 LIMI I:Incoming Correspondence |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2022-10-31 | 3 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2022-11-04 | 4 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2023-04-20 | 5 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2023-04-25 | 6 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2023-04-26 | 7 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2023-06-09 | 8 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2023-06-09 | 9 RFCS P: |
REFUSAL PROCESSED BY IB | 2023-07-04 | 10 RFNT P: |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2023-12-08 | 11 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2023-12-08 | 12 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2023-12-09 | 13 TEME I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-12-22 | 14 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2024-01-10 | 15 NONP E:E-Mail |
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2024-01-10 | 16 OP2R P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2024-01-10 | 17 OPNS P: |
PUBLISHED FOR OPPOSITION | 2024-01-30 | 18 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2024-01-30 | 19 NPUB E:E-Mail |
NOTIFICATION PROCESSED BY IB | 2024-01-30 | 20 GPNX P: |
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2024-03-20 | 21 OPNR P: |
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2024-03-20 | 22 OPNS P: |
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2024-04-08 | 23 OPNX P: |
REGISTERED-PRINCIPAL REGISTER | 2024-04-16 | 24 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2024-04-16 | 25 NRCC E:E-Mail |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2024-07-17 | 26 FICR P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.